Intellia Therapeutics Inc (NASDAQ:NTLA)

148.71
BATS BZX Real-Time Price
As of 1:55pm ET
 -8.25 / -5.26%
Today’s Change
18.81
Today|||52-Week Range
202.73
+173.36%
Year-to-Date
3 Red-Hot Healthcare Stocks to Buy in September
Sep 09 / MotleyFool.com - Paid Partner Content
3 Hot Stocks to Buy in September
Sep 07 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close156.96
Today’s open148.98
Day’s range146.76 - 153.46
Volume17,820
Average volume (3 months)1,859,706
Market cap$11.5B
Data as of 1:55pm ET, 09/20/2021

Growth & Valuation

Earnings growth (last year)-13.81%
Earnings growth (this year)-35.47%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+34.55%
P/E ratioNM
Price/Sales52.52
Price/Book19.75

Competitors

 Today’s
change
Today’s
% change
ZLABZai Lab Ltd-4.23-3.29%
CRSPCRISPR Therapeutics ...-8.20-6.59%
NBIXNeurocrine Bioscienc...-0.51-0.53%
BMRNBiomarin Pharmaceuti...-0.11-0.14%
Data as of 1:56pm ET, 09/20/2021

Financials

Next reporting dateNovember 2, 2021
EPS forecast (this quarter)-$0.83
Annual revenue (last year)$58.0M
Annual profit (last year)-$134.2M
Net profit margin-231.46%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts